EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma

Steven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, Patrick A DeSouza, Roberta L Beauchamp, Luke Witt, Xin Chen, Justin T Jordan, Thomas S K Gilbert, Anat Stemmer-Rachamimov, James F Gusella, Scott R Plotkin, Stephen J Haggarty, Long-Sheng Chang, Gary L Johnson, Vijaya Ramesh, Unknown, Annette Bakker, Salvatore La Rosa, Wade Clapp, Jaishri Blakeley, Helen Morrison, Bradley Welling, James Gusella, Stephen Haggarty, Scott Plotkin, Vijaya Ramesh, Anat Stemmer-Rachamimov, Long-Sheng Chang, Robert Allaway, Abhishek Pratap, Justin Guinney, Sage Bionetworks, Cristina Fernandez-Valle, Gary Johnson

Open source

DOI: 10.1093/neuonc/noy046
Published: 2018-03-21
Container: Neuro-Oncology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noy046,
  title = {EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma},
  author = {Steven P Angus and Janet L Oblinger and Timothy J Stuhlmiller and Patrick A DeSouza and Roberta L Beauchamp and Luke Witt and Xin Chen and Justin T Jordan and Thomas S K Gilbert and Anat Stemmer-Rachamimov and James F Gusella and Scott R Plotkin and Stephen J Haggarty and Long-Sheng Chang and Gary L Johnson and Vijaya Ramesh and Unknown and Annette Bakker and Salvatore La Rosa and Wade Clapp and Jaishri Blakeley and Helen Morrison and Bradley Welling and James Gusella and Stephen Haggarty and Scott Plotkin and Vijaya Ramesh and Anat Stemmer-Rachamimov and Long-Sheng Chang and Robert Allaway and Abhishek Pratap and Justin Guinney and Sage Bionetworks and Cristina Fernandez-Valle and Gary Johnson},
  year = {2018},
  journal = {Neuro-Oncology},
  doi = {10.1093/neuonc/noy046},
  url = {https://doi.org/10.1093/neuonc/noy046}
}

RIS

TY  - JOUR
TI  - EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma
AU  - Steven P Angus
AU  - Janet L Oblinger
AU  - Timothy J Stuhlmiller
AU  - Patrick A DeSouza
AU  - Roberta L Beauchamp
AU  - Luke Witt
AU  - Xin Chen
AU  - Justin T Jordan
AU  - Thomas S K Gilbert
AU  - Anat Stemmer-Rachamimov
AU  - James F Gusella
AU  - Scott R Plotkin
AU  - Stephen J Haggarty
AU  - Long-Sheng Chang
AU  - Gary L Johnson
AU  - Vijaya Ramesh
AU  - Unknown
AU  - Annette Bakker
AU  - Salvatore La Rosa
AU  - Wade Clapp
AU  - Jaishri Blakeley
AU  - Helen Morrison
AU  - Bradley Welling
AU  - James Gusella
AU  - Stephen Haggarty
AU  - Scott Plotkin
AU  - Vijaya Ramesh
AU  - Anat Stemmer-Rachamimov
AU  - Long-Sheng Chang
AU  - Robert Allaway
AU  - Abhishek Pratap
AU  - Justin Guinney
AU  - Sage Bionetworks
AU  - Cristina Fernandez-Valle
AU  - Gary Johnson
PY  - 2018
JO  - Neuro-Oncology
DO  - 10.1093/neuonc/noy046
UR  - https://doi.org/10.1093/neuonc/noy046
ER  -

APA

Angus, S. P., Oblinger, J. L., Stuhlmiller, T. J., DeSouza, P. A., Beauchamp, R. L., Witt, L., Chen, X., Jordan, J. T., Gilbert, T. S. K., Stemmer-Rachamimov, A., Gusella, J. F., Plotkin, S. R., Haggarty, S. J., Chang, L., Johnson, G. L., Ramesh, V., Unknown, Bakker, A., Rosa, S. L., Clapp, W., Blakeley, J., Morrison, H., Welling, B., Gusella, J., Haggarty, S., Plotkin, S., Ramesh, V., Stemmer-Rachamimov, A., Chang, L., Allaway, R., Pratap, A., Guinney, J., Bionetworks, S., Fernandez-Valle, C., & Johnson, G. (2018). EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noy046

Source records

crossref · retrieved 2026-09-26T03:22:40.100Z